CUTISS AG

Established in 2017, CUTISS is a Swiss clinical-stage life sciences company focused on regenerative medicine, tissue engineering, and skin pigmentation... Our team consists of over 40 employees, top notch senior executives, advisors and investors. It includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise... CUTISS has developed first-in-class machine for the automated production of tissue therapy. To secure scale-up, allow decentralization and achieve relevant cost reduction for the manufacturing of denovoSkin, CUTISS has been developing first-in-class automated bio-reactors with leading Swiss and international engineering partners. This pioneering, proprietary platform may also be used beyond skin for the next-priority human tissues (muscle, gums, etc.) in the future.

Also known as: Cutiss

Primary location: Schlieren Switzerland